Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of daptomycin in Japan
jRCT2080224094Phase 2Completed
- Start
- Oct 2018
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of daptomycin. Started Oct 2018; status: completed.
02
Drugs
daptomycin
Beyond the preview
Go deeper on jRCT2080224094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224094.